Cefpodoxime

Common Uses

Cefpodoxime is prescribed to treat a wide range of infections caused by bacteria. It belongs to a class of drugs known as cephalosporin antibiotics, which work by stopping the growth of bacteria.

Healthcare providers commonly use this medication for the following conditions:

• Respiratory tract infections: This includes community-acquired pneumonia, acute worsening of chronic bronchitis, and sinus infections (sinusitis).
• Ear, nose, and throat infections: It is used to treat middle ear infections (otitis media) as well as throat infections like pharyngitis or tonsillitis.
• Urinary tract infections: Cefpodoxime is used for uncomplicated infections of the bladder, such as cystitis.
• Skin infections: It is effective against certain bacterial infections of the skin and skin structures.
• Sexually transmitted infections: It may be prescribed for uncomplicated gonorrhea affecting the urethra or cervix.

It is important to note that cefpodoxime only treats bacterial infections. It will not work for viral infections, such as the common cold, the flu, or most coughs and sore throats. Using antibiotics when they are not needed increases the risk of getting an infection later that resists antibiotic treatment.

Mechanism of Action

Cefpodoxime belongs to a class of medications known as cephalosporin antibiotics. It is specifically categorized as a third-generation cephalosporin, which is designed to be effective against a wide range of bacteria.

This medication works by targeting the structural integrity of bacteria. To survive and multiply, bacteria must build and maintain a protective outer layer called a cell wall. Cefpodoxime works by:

• Inhibiting cell wall synthesis: It prevents bacteria from properly knitting together the molecules needed to build their cell walls.
• Causing cell death: Without a stable cell wall, the bacteria cannot withstand the pressure from their internal environment. This causes the bacterial cells to burst and die.

Because human cells do not have cell walls, the medication specifically targets the bacteria causing the infection without harming the patient's own cells in the same way. This type of action is described as bactericidal, meaning the drug actively kills the bacteria rather than just slowing their growth.

Scope of Activity

Cefpodoxime is effective only against infections caused by bacteria. It is not effective against viral infections, such as the common cold or the flu. Using antibiotics when they are not needed increases the risk of developing an infection later that resists antibiotic treatment.

Common Side Effects

Many people using cefpodoxime do not experience significant side effects. When they do occur, common symptoms may include:

• Diarrhea or loose stools
• Nausea or vomiting
• Stomach pain or upset
• Headache
• Vaginal itching or discharge
• Diaper rash in infants

Serious Side Effects

Contact a healthcare provider immediately if you experience any of the following serious symptoms:

• Signs of an allergic reaction, such as skin rash, hives, itching, or swelling of the face, lips, tongue, or throat
• Difficulty breathing or swallowing
• Severe stomach cramps or watery or bloody diarrhea
• Fever, sore throat, or chills
• Unusual bruising or bleeding
• Yellowing of the eyes or skin
• Extreme tiredness or weakness
• Joint or muscle pain

Severe diarrhea caused by an overgrowth of bacteria in the intestines is a serious condition that can occur during treatment or several months after the last dose. Do not use anti-diarrhea products without consulting a doctor if you have watery or bloody stools, as these products may make the condition worse.

Allergic Reactions

Serious and occasionally fatal hypersensitivity reactions have been reported with cefpodoxime. Before starting therapy, it is important to identify any previous history of hypersensitivity to cefpodoxime, other cephalosporins, or penicillins. There is a risk of cross-sensitivity among beta-lactam antibiotics, which may occur in approximately 10% of patients with a history of penicillin allergy.

Clostridioides Difficile-Associated Diarrhea

Nearly all antibacterial agents, including cefpodoxime, can cause Clostridioides difficile-associated diarrhea (CDAD). This condition ranges in severity from mild diarrhea to fatal colitis. It occurs because the antibiotic alters the normal flora of the colon, allowing C. difficile to overgrow. CDAD must be considered in any patient who experiences diarrhea following antibiotic use.

Kidney Impairment and Seizure Risk

In patients with severe kidney impairment, the dosage of cefpodoxime should be adjusted. High doses of cephalosporins in patients with renal failure have been associated with the occurrence of seizures when the dosage was not appropriately reduced.

General Precautions

• Drug Resistance: Prescribing cefpodoxime in the absence of a proven or strongly suspected bacterial infection is unlikely to provide benefit and increases the risk of developing drug-resistant bacteria.
• Superinfection: As with other antibiotics, prolonged use of cefpodoxime may result in the overgrowth of non-susceptible organisms.
• Blood Clotting: Some cephalosporins have been associated with a reduction in prothrombin activity. Those at higher risk include patients with kidney or liver impairment or those with poor nutritional status.
• Pregnancy and Lactation: Cefpodoxime should be used during pregnancy only if clearly needed. Because the drug is excreted in human milk, caution is advised when administered to nursing women.

Pregnancy

Studies in animals have not shown cefpodoxime to cause harm to the developing fetus. However, there are no adequate and well-controlled studies in pregnant women to confirm its safety. Because animal studies are not always predictive of human response, this medication should be used during pregnancy only if a healthcare provider determines it is clearly needed.

Breastfeeding

Cefpodoxime is excreted into human breast milk. While it is often used during nursing, there is a potential for the medication to affect the nursing infant. Healthcare providers typically consider the following risks:

• Changes in the infant's digestive bacteria, which may lead to diarrhea.
• The development of oral thrush (a yeast infection in the mouth).
• The risk of an allergic reaction if the infant is sensitive to cephalosporin antibiotics.

A decision should be made whether to stop breastfeeding or to stop taking the medication, depending on how important the drug is to the mother's health. Patients should discuss the potential risks and benefits with their clinician before using cefpodoxime while nursing.

Available Forms

Cefpodoxime is available in the following oral formulations:

• Tablets: These are film-coated tablets designed for oral administration.
• Oral Suspension: This is a powder that is mixed with water to form a liquid. It is typically used for children or adults who have difficulty swallowing solid pills.

FDA Approval Status

Cefpodoxime proxetil was first approved by the U.S. Food and Drug Administration (FDA) in 1992. It is currently available as a prescription-only medication in tablet and oral suspension forms.

Approved Indications

The FDA has approved cefpodoxime for the treatment of specific infections caused by susceptible bacteria. These include:

• Acute community-acquired pneumonia
• Acute bacterial exacerbations of chronic bronchitis
• Acute maxillary sinusitis
• Pharyngitis and tonsillitis
• Uncomplicated urinary tract infections
• Uncomplicated skin and skin structure infections
• Uncomplicated gonorrhea

Safety and Oversight

Cefpodoxime is not subject to a boxed warning or a Risk Evaluation and Mitigation Strategy (REMS) program. Regulatory labeling includes precautions regarding the potential for hypersensitivity reactions and the risk of Clostridioides difficile-associated diarrhea, which is common to many broad-spectrum antibiotics. To prevent the development of drug-resistant bacteria, the FDA recommends that cefpodoxime be used only to treat infections confirmed or strongly suspected to be bacterial.

Generic Availability

Cefpodoxime is widely available as a generic drug in both tablet and oral suspension forms. Generic medications are required to have the same active ingredients and strength as brand-name versions but are usually offered at a lower price.

Factors Affecting Price

The out-of-pocket cost for cefpodoxime can vary based on several factors:

• Insurance Coverage: Most insurance plans and Medicare Part D cover generic cefpodoxime, though the specific copayment depends on the plan's formulary tier.
• Formulation: The price may differ between the tablet form and the liquid oral suspension.
• Pharmacy Choice: Retail prices can vary significantly between different pharmacies, including local drugstores, grocery store pharmacies, and mail-order services.
• Treatment Duration: The total cost is influenced by the number of days the medication is prescribed for and the specific dosage required.

For those without insurance, many pharmacies offer discount programs or savings cards that can help reduce the cost of generic antibiotics like cefpodoxime.